Substituted-4-quinolones
AssigneeThe Secretary of State for Defense
InventorsDavid Idris Pritchard, Barrie Walsham Bycroft, Siri Ram Chhabra, Doreen Hooi
Life of this patent
Estimating the term…
Loading patent…
AssigneeThe Secretary of State for Defense
InventorsDavid Idris Pritchard, Barrie Walsham Bycroft, Siri Ram Chhabra, Doreen Hooi
Estimating the term…
Substituted-4-quinolones of the formula (I): wherein R1 is a straight or branched chain, saturated or ethylenically-unsaturated aliphatic hydrocarbyl group containing 1 to 18 carbon atoms which may optionally be substituted by one or more substituent groups selected from halo, 1-6C alkoxy, carboxy, 1-6C alkoxycarbonyl and NR6R7, wherein each of R6 and R7 is independently selected from H and 1-6C alkyl or R6 and R7 together with the N atom to which they are attached form a saturated heterocyclic group selected from piperidino, piperazino and morpholino. R2 is a group selected from H, —OH, halo, —CHO, —CO2H and CONHR8 wherein R8 is H or a 1-6C alkyl; each of R3, R4 and R1 is independently selected form H, —CH3, —OCH3 and halo; or a non-toxic pharmaceutically-acceptable salt thereof, have use in the manufacture of a medicament for the treatment of a disease of a living animal body, including a human, which disease is responsive to the activity of an immunosuppressant. The preferred compound of the formula 1 is 2-n-heptyl-3-hydroxy-4(1H)-quinolone.
The use of a compound of the formula I
A method of treating a disease of a living animal body, including a human, which disease is responsive to the activity of an immunosuppressant which method comprises administering to the living animal body, including a human, a therapeutically-effective amount of a compound of the formula I
Dependencies are inferred from the claim text.